MAFS, it is time for a reality check on solariums.
7 February 2020
Dear MAFS fans, we need to talk.
Who watched newly-wed Natasha last night rattling off her weekly ‘beauty’ routine to husband Mikey? ‘Botox, fillers, nails, hair…facials,massages, fat freezing, solarium…’
Please tell me I didn’t just hear ‘solarium’? Hearing a vibrant and educated 26 year old, with her life and world ahead of her, so casually mention her solarium use should have sent chills up your spine.
And this is why:
1. Solarium use greatly increases your risk of deadly melanoma – conclusive research on patients under 40 showed those who'd had more than 10 solarium visits in their life had up to a seven-times greater risk of developing melanoma.
2. Melanoma kills one Australian every five hours, and is the most common cancer affecting 15 to 39 year old Ausssies.
3. Commercial solariums are illegal across Australia – Melanoma Institute Australia research was integral in them being banned due to the clear link between solarium use and melanoma.
Natasha didn’t detail where she uses the solarium, but odds are there was one backyard operator sitting on their couch last night breathing a big sigh of relief that their illegal underground commercial sunbed operation wasn’t outed on national television.
Natasha’s weekly ‘beauty’ routine has today been discussed, dissected and debated online, on social media and on radio, mainly for laughs. But this is a serious issue, a potentially deadly one in fact.
The research is clear that whatever type of solarium you're using, in a home or an illegal backyard commercial operation - none of them are safe.
At a time when families across Australia are preparing to take part in Melanoma March events in memory of loved ones they have lost to melanoma, it was confronting, but most of all sad, to see a young woman choosing to put her health at risk for a tan.
It is time all Australians took melanoma seriously, including reality TV shows that air such comments so flippantly. Surely the lives of young Australians are more valuable than that.
Matthew Browne - CEO, Melanoma Institute Australia
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.